Sarcoidosis of the Nervous System, A Clinical Approach
Arch Int Med 151:1317-1321, Sharma,Om.P.&Sharma,A.D., 1991
Evoked Potentials in Chronic Inflammatory Demyelinating Polyneuropathy
Arch Neurol 45:1014-1016, Pakalnis,A.,et al, 1988
Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
Lancet 390:2481-2489, Green, A.J.,et al, 2017
Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001
Practice Parameter: The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients With Suspected Multiple Sclerosis (an Evidence-Based Review)
Neurol 54:1720-1725, Gronseth,G.S.&Ashman,E.J., 2000
Disturbance of Cerebral Function in People Exposed to Drinking Water Contaminated with Aluminum Sulphate:Retrospective Study of the Camelford Water Incident
BMJ 319:807-811, Altmann,P.,et al, 1999
Evaluation of Neurologic Function in Gulf War Veterans:A Blinded Case-Control Study
JAMA 227:223-230, 2591997., Haley,R.W.,et al, 1997
Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997
Clinical and Subclinical Neurological Involvement in Children of Conjugal Multiple Sclerosis Patients
Multiple Sclerosis 1:170-172, Constantinescu,C.S.,et al, 1996
The"Gulf War Syndrome"-Is There Evidence of Dysfunction in the Nervous System
JNNP 60:449-451, Jamal,G.A.,et al, 1996
Charcot-Marie-Tooth Neuropathies:From Clinical Description to Molecular Genetics
Muscle & Nerve 18:267-275995., Ionasecu,V.V., 1995
Investigation of Peripheral Neuropathy
JNNP 58:274-283, McLeod,J.G., 1995
Neurological Multisystem Manifestation in Multiple Symmetric Lipomatosis:A Clinical and Electrophysiological Study
Muscle & Nerve 18:693-698995., Naumann,M.,et al, 1995
A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994
Brain MRI and Electrophysiologic Abnormalities in Preclinical and Clinical Adrenomyeloneuropathy
Neurol 42:85-91, Aubourg,P.,et al, 1992
Intra-arterial Cisplatin-Associated Optic and Otic Toxicity
Arch Neurol 49:83-86, Maiese,K.,et al, 1992
Symptomatic Retrochiasmal Lesions in MS:Clinical Features, Visual Evoked Potentials, and Magnetic Resonanc Imaging
Neurol 42:68-76, Plant,G.T.,et al, 1992
Evoked Potentials in Cerebrotendinous Xanthomatosis and Effect Induced by Chenodeoxycholic Acid
Arch Neurol 49:469-475, Mondelli,M.,et al, 1992
The Diagnostic Reliability of Magnetically Evoked Motor Potentials In Multiple Sclerosis
Neurol 42:1296-1301, Ravnborg,M.,et al, 1992
Brain-Stem Auditory Evoked Potential Abnormalities with Unilateral Brain-Stem Lesions Demonstrated by MRI
Arch Neurol 46:295-299, Markand,O.N.,et al, 1989
Progressive Neurological Dysfunction During Latent HIV Infection
BMJ 299:225-228, Jakobsen,J.,et al, 1989
Disturbance of Cerebral Function by Aluminium in Haemodialysis Patients without Overt Aluminium Toxicity
Lancet 2:7-12, Altmann,P.,et al, 1989
MRI in the Diagnosis of MS:Comparison of Clinical Eval, Evoked Potentials, Oligoclonal Banding, & CT
Neurol 38:180-185, 309-3141988., Paty,D.W.,et al, 1988
Acoustic Nerve Conduction Abnormalities in Guillain-Barre Syndrome
Neurol 38:1263-1266, Nelson,K.R.,et al, 1988
Antibody to Human T-Lymphotropic Virus Type I In West-Indian-Born UK Residents with Spastic Paraparesis
Lancet 1:415-416, Newton,M.,et al, 1987
Long-Term Survival in Acute Arsenic Encephalopathy, Follow-up Using Newer Measures of Electrophysiologic Parameters
Am J Med 82:549-552, Fincher,R.E.,et al, 1987
Trimodal Evoked Potentials Compared with Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis
Arch Neurol 44:281-284, Geisser,B.S.,et al, 1987
Magnetic Resonance Imaging in Isolated Noncompressive Spinal Cord Syndromes
Ann Neurol 22:714-723, Miller,D.H.,et al, 1987
Evoked Potentials in Guillain-Barre Syndrome
Neurol 36:587-590, Ropper,A.H.&Chiappa,K.H., 1986
Visual & Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
NEJM 314:869-873, Olivieri,N.F.,et al, 1986
Giant Axonal Neuropathy:Central Abnormalities Demonstrated by Evoked Potentials
Ann Neurol 19:394-396, Majnemer,A.,et al, 1986
Multiple Sclerosis:Magnetic Resonance Imaging, Evoked Responses, & Spinal Fluid Electroporesis
Neurol 36:828-831, Farlow,M.R.,et al, 1986
Nitrous Oxide:Clinical & Electrophysiologic Investigation of Neurologic Complications
Neurol 36:1618-1622, Heyer,E.J.,et al, 1986
Evaluation of Patients with Multiple Sclerosis by Evoked Potentials & Magnetic Resonance Imaging:A Compar Study
Ann Neurol 20:645-648, Cutler,J.R.,et al, 1986
Clinicopathological Conference Metachromatic Leukodystrophy (juvenile type)
Case 7-1984, NEJM 310:445-4551984., , 1984
Abnormalities in Central Motor Pathway Conduction in Multiple Sclerosis
Lancet 2:304-307, Cowan,J.M.,et al, 1984
The Diagnosis & Classification of Multiple Sclerosis:Evoked Responses & Spinal Fluid Electrophoresis
Neurol 33:611-617, Bartel,D.R.,et al, 1983
New Diagnostic Criteria for Multiple Sclerosis:Guidelines for Research Protocols
Neurol 13:227-231, Poser,C.M.,et al, 1983
Clin. Path. Conference
Adrenoleukodystrophy, with Peripheral Neuropathy, Case Record 5-1982, NEJM 306:286-29382., , 1982
The Diagnosis of Multiple Sclerosis
JAMA 247:498-503, Hart,R.G.,et al, 1982
Evoked Potentials In Clinical Medicine, (First of Two Parts)
NEJM 306:1140-1150, Chiappa,K.H.,et al, 1982
Evoked Potentials in Neurological Diagnosis
BMJ 285:1678-1679, Mastaglia,F.L.,et al, 1982
Multimodality Evoked Potentials & Blink Reflex in Multiple Sclerosis
Neurol 31:138-144, Khoshbin,S.,et al, 1981